
Burning Rock Biotech Limited BNR
$ 20.15
-2.3%
Annual report 2021
added 12-23-2023
Burning Rock Biotech Limited P/S Ratio 2011-2026 | BNR
Annual P/S Ratio Burning Rock Biotech Limited
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| - | 6.87 | - | - | - | - | - | - | - | - | - |
All numbers in CNY currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 6.87 | 6.87 | 6.87 |
P/S Ratio of other stocks in the Diagnostics research industry
| Issuer | P/S Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Akumin
AKU
|
0.1 | - | -17.87 % | $ 25.9 M | ||
|
Centogene N.V.
CNTG
|
1.72 | - | -6.23 % | $ 30.6 M | ||
|
Accelerate Diagnostics
AXDX
|
13.5 | - | -61.36 % | $ 2.46 M | ||
|
Brainsway Ltd.
BWAY
|
8.09 | $ 19.02 | 0.21 % | $ 99.4 M | ||
|
Co-Diagnostics
CODX
|
5.13 | $ 0.17 | -6.7 % | $ 4.99 M | ||
|
Danaher Corporation
DHR
|
6.37 | $ 228.92 | -0.76 % | $ 167 B | ||
|
Biocept
BIOC
|
0.229 | - | -13.05 % | $ 7.29 M | ||
|
Chembio Diagnostics
CEMI
|
0.254 | - | 0.22 % | $ 16.8 M | ||
|
DexCom
DXCM
|
13.5 | $ 66.37 | -1.03 % | $ 25.6 B | ||
|
BioNano Genomics
BNGO
|
0.115 | $ 1.53 | 2.0 % | $ 1.94 M | ||
|
Castle Biosciences
CSTL
|
2.14 | $ 38.9 | -1.04 % | $ 1.08 B | ||
|
Oxford Immunotec Global PLC
OXFD
|
5.71 | - | - | $ 562 M | ||
|
DermTech
DMTK
|
2.77 | - | -11.32 % | $ 2.94 M | ||
|
DarioHealth Corp.
DRIO
|
2.13 | $ 11.38 | 6.36 % | $ 323 M | ||
|
IQVIA Holdings
IQV
|
2.31 | $ 225.41 | -1.0 % | $ 40.9 B | ||
|
Enzo Biochem
ENZ
|
0.0018 | - | -8.98 % | $ 14.8 K | ||
|
Exact Sciences Corporation
EXAS
|
3.38 | $ 101.56 | -0.33 % | $ 18.8 B | ||
|
Fulgent Genetics
FLGT
|
1.65 | $ 26.27 | -0.83 % | $ 794 M | ||
|
Global Cord Blood Corporation
CO
|
0.196 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
3.48 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
1.36 K | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
2.9 | - | 0.12 % | $ 80.1 M | ||
|
PRA Health Sciences, Inc.
PRAH
|
2.47 | - | - | $ 10.7 B | ||
|
Myriad Genetics
MYGN
|
1.16 | $ 6.15 | -0.32 % | $ 557 M | ||
|
CareDx, Inc
CDNA
|
1.86 | $ 18.84 | -1.21 % | $ 1.01 B | ||
|
NeoGenomics
NEO
|
2.31 | $ 11.76 | -3.84 % | $ 1.49 B | ||
|
National Research Corporation
NRC
|
6.79 | $ 18.77 | 0.64 % | $ 461 M | ||
|
Anixa Biosciences
ANIX
|
0.337 | $ 3.12 | - | $ 99.5 K | ||
|
Precipio
PRPO
|
0.572 | $ 22.98 | -1.84 % | $ 29.8 M | ||
|
Personalis
PSNL
|
3 | $ 7.96 | -0.13 % | $ 472 M | ||
|
Heska Corporation
HSKA
|
3.28 | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
0.469 | - | -20.0 % | $ 1.06 M | ||
|
Guardant Health
GH
|
7.91 | $ 102.14 | 1.53 % | $ 12.5 B | ||
|
Aspira Women's Health
AWH
|
5.55 | - | -6.19 % | $ 10.5 M | ||
|
ENDRA Life Sciences
NDRA
|
1.59 K | $ 4.53 | -4.83 % | $ 2.43 M | ||
|
Soleno Therapeutics
SLNO
|
9.03 | $ 46.3 | 0.02 % | $ 1.86 B | ||
|
Illumina
ILMN
|
3.75 | $ 131.16 | -1.2 % | $ 20.9 B | ||
|
Charles River Laboratories International
CRL
|
2.11 | $ 199.48 | -1.24 % | $ 10.2 B | ||
|
Thermo Fisher Scientific
TMO
|
4.8 | $ 579.45 | -0.69 % | $ 221 B | ||
|
Trinity Biotech plc
TRIB
|
1.47 | $ 0.79 | -3.54 % | $ 61.9 M | ||
|
Quest Diagnostics Incorporated
DGX
|
1.93 | $ 173.53 | -1.12 % | $ 19.3 B | ||
|
Biodesix
BDSX
|
1.29 | $ 6.8 | 1.19 % | $ 882 M | ||
|
Motus GI Holdings
MOTS
|
3.1 | - | -34.28 % | $ 263 K | ||
|
Laboratory Corporation of America Holdings
LH
|
1.62 | $ 250.88 | -0.87 % | $ 21 B | ||
|
Twist Bioscience Corporation
TWST
|
4.15 | $ 31.72 | -1.34 % | $ 1.9 B | ||
|
ICON Public Limited Company
ICLR
|
3.25 | $ 182.22 | -0.43 % | $ 15 B | ||
|
IDEXX Laboratories
IDXX
|
9.66 | $ 676.53 | -0.85 % | $ 55.8 B | ||
|
Lantheus Holdings
LNTH
|
4.21 | $ 66.55 | -0.91 % | $ 4.61 B |